LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Campylobacter Rely on Pseudomonas to Infect Humans

By LabMedica International staff writers
Posted on 27 Oct 2010
The interaction between the different species of bacteria seems to be a mechanism for Campylobacter jejuni to remain viable and survive ambient oxygen levels.

C. jejuni is a microaerophilic gram-negative bacillus that causes febrile diarrhea or dysentery; vomiting or bloody stool are often noted with severe abdominal pain. The disease is most common among children and lasts one to four days.

Although Campylobacter infections are rarely life threatening, they are extremely debilitating and they have been linked with the development of Guillain-Barré syndrome, one of the leading causes of nontrauma-induced paralysis worldwide. The bacteria do not grow well at room temperature or in an oxygen-rich environment as it well adapted to life in the intestines of animals and humans. However, it is normally transmitted from contaminated chicken meat, as it is frequently found in the intestines of chickens, where it apparently does not result in any symptoms.

Scientists at the University of Veterinary Medicine (Vienna, Austria), have recently discovered that interactions with other bacteria allow C. jejuni to survive under hostile, oxygen-rich conditions. Campylobacter survived atmospheric oxygen levels for no longer than 18 hours when incubated alone or together with bacteria such as Proteus mirabilis, Citrobacter freundii, Micrococcus luteus or Enterococcus faecalis. However, when incubated together with various strains of Pseudomonas, Campylobacter were found to survive for much longer, in some cases over 48 hours, which would be easily long enough to cause infection. An in vitro assay was used to test the bacteria's survival rate.

There were differences in the extent of prolonged survival depending on the sources of the Campylobacter analyzed, but all isolates of all strains clearly survived significantly longer in the presence of Pseudomonas bacteria than when cultured alone. And the Campylobacter cells did not change shape when cultured together with Pseudomonas under oxygen-rich conditions, unlike when they were cultured alone, providing further indications of an interaction between the species. Interestingly, there is no evidence that the Pseudomonas benefit at all from the interaction, although they effectively facilitate the survival of Campylobacter under adverse conditions.

This microbial commensalism was diverse in C. jejuni isolates from different sources: isolates from chicken meat and humans in coculture with Ps. putida were able to use this survival support better than fecal isolates from broilers. Scanning electron microscopy revealed the development of fiber-like structures braiding Ps. putida and C. jejuni cells. Hence, it seems that microaerophilic C. jejuni is able to survive ambient atmospheric oxygen tension by metabolic commensalism with Pseudomonas species. This bacterial-bacterial interaction might set the basis for the survival of C. jejuni on chicken meat and thus be the prerequisite step in the pathway towards human infection. The study was published the October 2010 issue of Applied and Environmental Microbiology.

Related Links:
University of Veterinary Medicine



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Human Estradiol Assay
Human Estradiol CLIA Kit

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more